Citing fears of vertical integration and reduced competition, anti-monopoly advocacy group American Economic Liberties Project and a small cadre of other advocacy organizations are urging federal regulators to block two recent oncology practice network deals. The purchases in question are McKesson Corporation’s $2.5 billion bid for a controlling stake in the Florida Cancer Specialists & Research Institute’s management services organization, Core Ventures; and Cardinal Health’s $1.1 billion deal for Integrated Oncology Network. Both deals were announced within the past month and would see a large wholesale pharmaceutical distributor and a healthcare supply and services company strengthen their positions in the “highly consolidated” oncology practice management services market, they wrote.
Read the full article: Anti-Monopoly Advocates Urge FTC to Block McKesson, Cardinal Health’s Big-Ticket Oncology Acquisitions //
Source: https://www.fiercehealthcare.com/regulatory/advocates-urge-ftc-block-mckesson-cardinal-healths-big-ticket-oncology-acquisitions